The Mysteries of Lipoprotein(a) and Cardiovascular Disease Revisited**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- 1 May 2010
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 55 (19) , 2168-2170
- https://doi.org/10.1016/j.jacc.2009.12.048
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Apolipoprotein(a) Isoforms and the Risk of Vascular DiseaseJournal of the American College of Cardiology, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6qJournal of Lipid Research, 2009
- The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicityCurrent Opinion in Lipidology, 2008
- Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular OutcomesArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Lipoprotein(a)Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal modelsClinical Biochemistry, 2004
- Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in AtherogenesisCirculation, 1999
- The Mysteries Of Lipoprotein(a)Science, 1989
- A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEMActa Pathologica Microbiologica Scandinavica, 1963